홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Ammonium formate → Tert-butyl 4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]piperazine-1-carboxylate

HRID 2381094
인쇄

반응식

HRID 2381094 반응식
[F:1][C:2]([F:41])([F:40])[C:3]1[N:7]2[N:8]=[C:9]([N:12]3[CH2:17][CH2:16][CH:15]([C:18]4[CH:39]=[CH:38][C:21]([O:22][CH2:23][CH2:24][N:25]5[CH2:30][CH2:29][N:28]([C:31]([O:33][C:34]([CH3:37])([CH3:36])[CH3:35])=[O:32])[CH2:27][CH2:26]5)=[CH:20][CH:19]=4)[CH2:14][CH2:13]3)[CH:10]=[CH:11][C:6]2=[N:5][N:4]=1.C([O-])=O.[NH4+]>[Pd].C(O)C>[F:41][C:2]([F:1])([F:40])[C:3]1[N:7]2[N:8]=[C:9]([N:12]3[CH2:13][CH2:14][CH:15]([C:18]4[CH:19]=[CH:20][C:21]([O:22][CH2:23][CH2:24][N:25]5[CH2:26][CH2:27][N:28]([C:31]([O:33][C:34]([CH3:35])([CH3:36])[CH3:37])=[O:32])[CH2:29][CH2:30]5)=[CH:38][CH:39]=4)[CH2:16][CH2:17]3)[CH2:10][CH2:11][C:6]2=[N:5][N:4]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 2723923Ammonium formate2회HCID 66788098Tert-butyl 4-[2-[4-[1-(3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]piperazine-1-carboxylate

생성물 1

HCID 68503507Tert-butyl 4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]piperazine-1-carboxylate수율 81%

시약·촉매·용매 2

HCID 23938
Palladium
촉매
HCID 702Ethanol용매

실험 절차

10% Palladium on carbon (0.924 g, 0.87 mmol) was added to tert-butyl 4-[2-[4-[1-(3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]phenoxy]ethyl]piperazine-1-carboxylate (2.5 g, 4.34 mmol) and ammonium formate (2.74 g, 43.43 mmol) in ethanol (100 mL). The resulting mixture was stirred at 78° C., with further portions of ammonium formate being added every 5 hours until the reaction was complete. The reaction mixture was cooled to room temperature and the catalyst was removed by filtration. The filtrate was evaporated to dryness, redissolved in DCM (100 mL) and the solution was washed with water (100 mL) followed by brine (50 mL), then the solvents were evaporated to afford tert-butyl 4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]piperazine-1-carboxylate (2.020 g, 81%) as a solid.

후처리

  1. additionadded every 5 hours until the reaction
  2. customthe catalyst was removed by filtration
  3. customThe filtrate was evaporated to dryness
  4. dissolutionredissolved in DCM (100 mL)
  5. washthe solution was washed with water (100 mL)
  6. customthe solvents were evaporated

출처 및 근거

ORD 기록
ord-fb97b0751f3c40438c67463519a8ff39
출처 데이터셋
uspto-grants-2012_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08258140B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트